Viewing Study NCT03017495



Ignite Creation Date: 2024-05-06 @ 9:33 AM
Last Modification Date: 2024-10-26 @ 12:16 PM
Study NCT ID: NCT03017495
Status: COMPLETED
Last Update Posted: 2018-07-10
First Post: 2017-01-10

Brief Title: A Clinical Study to Investigate the Potential Interactions Between Food and ACT-541468 and Between ACT-541468 and Midazolam
Sponsor: Idorsia Pharmaceuticals Ltd
Organization: Idorsia Pharmaceuticals Ltd

Study Overview

Official Title: A Single-center Open-label Study to Investigate the Food Effect on the Pharmacokinetics of ACT-541468 and the Effect of Single- and Multiple-dose ACT-541468 on the Pharmacokinetics of Midazolam and Its Metabolite 1-Hydroxymidazolam in Healthy Male Subjects
Status: COMPLETED
Status Verified Date: 2018-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The main objectives of this phase 1 trial are to evaluate the effect of food on the pharmacokinetics ie how long and how much a compound is present in the blood of ACT-541468 and to evaluate whether ACT-541468 can affect the pharmacokinetics of midazolam a CYP3A4 substrate
Detailed Description: Food effect will be assessed by comparing the pharmacokinetic PK parameters of a single dose of ACT-541468 under fasted Treatment B and fed Treatment C conditions

Potential CYP3A4 inhibiting inducing effects of ACT-541468 will be assessed by comparing the PK parameters of midazolam alone Treatment A and midazolam given with a single dose of ACT-541468 Treatment B or with multiple doses of ACT-541468 Treatment D

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
2016-003490-18 EUDRACT_NUMBER None None